Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests, for the first time, that Roquin, by down regulation of its target gene, it may increase the expression of tumor suppressor BTG2. Thus, pharmacological formulations containing “Roquin activators” can be used in the treatment of human cancers.
To cite: Boominathan, Molecular therapy for Human Cancer: Roquin [RING finger and CCCH-type zinc finger domain-containing protein 1] increases the expression of tumor suppressor BTG2 via down regulation of its target gene, 14/March/2015, 18.18, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Undisclosed information: How Roquin increases the expression of BTG2